Cargando…

Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988086/
https://www.ncbi.nlm.nih.gov/pubmed/35399569
http://dx.doi.org/10.21037/tlcr-2022-1
_version_ 1784682885634064384
collection PubMed
description
format Online
Article
Text
id pubmed-8988086
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-89880862022-04-08 Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer Transl Lung Cancer Res Erratum AME Publishing Company 2022-03 /pmc/articles/PMC8988086/ /pubmed/35399569 http://dx.doi.org/10.21037/tlcr-2022-1 Text en 2022 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Erratum
Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
title Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
title_full Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
title_fullStr Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
title_full_unstemmed Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
title_short Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
title_sort erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988086/
https://www.ncbi.nlm.nih.gov/pubmed/35399569
http://dx.doi.org/10.21037/tlcr-2022-1
work_keys_str_mv AT erratumtocombingstereotacticbodyradiotherapywithcheckpointinhibitorsafteroligoprogressioninadvancednonsmallcelllungcancer